Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial

2015 ◽  
Vol 16 (13) ◽  
pp. 1295-1305 ◽  
Author(s):  
Alan K Burnett ◽  
Nigel H Russell ◽  
Robert K Hills ◽  
David Bowen ◽  
Jonathan Kell ◽  
...  
Keyword(s):  
Retinoic Acid ◽  
Arsenic Trioxide ◽  
Acute Promyelocytic Leukaemia ◽  
Acid Treatment ◽  
Risk Groups ◽  
Retinoic Acid Treatment ◽  
Phase 3 ◽  
Trans Retinoic Acid ◽  
All Trans Retinoic Acid ◽  
Randomised Controlled

scholarly journals Arsenic trioxide and all‐trans retinoic acid treatment for childhood acute promyelocytic leukaemia

2018 ◽  
Vol 185 (2) ◽  
pp. 360-363 ◽  
Author(s):  
Luisa Strocchio ◽  
Carmelo Gurnari ◽  
Nicola Santoro ◽  
Maria C. Putti ◽  
Concetta Micalizzi ◽  
...  
Keyword(s):  
Retinoic Acid ◽  
Arsenic Trioxide ◽  
Acute Promyelocytic Leukaemia ◽  
Acid Treatment ◽  
Promyelocytic Leukaemia ◽  
Retinoic Acid Treatment ◽  
Trans Retinoic Acid ◽  
All Trans Retinoic Acid
Sign in / Sign up

Export Citation Format

Share Document